Summary
Research and development focused on digital health technology to derive biomarkers and outcome assessments for remote monitoring and endpoint development, potentially involving clinical trials.
Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development (UG3/UH3 - Clinical Trial Optional)
US
National Institutes of Health
grant
open
#grants-gov-PAR-25-170
Response due Jun 22, 2026 · 00:00 UTC
Risks & flags
- This is a grant opportunity (UG3/UH3 mechanism) listed on Grants.gov, not a traditional procurement contract (RFP, IFB, RFQ, or sole-source notice).
